AKT1 and amyotrophic lateral sclerosis: Therefore, therapeutic strategies for ALS targeting the PI3K-Akt pathway has been shown to increase anti-apoptotic protein expression levels, reduce pro-apoptotic protein expression levels, and improve cell survival rate and mitochondrial function in ALS90.